- Short report
- Open Access
Dengue viruses binding proteins from Aedes aegypti and Aedes polynesiensis salivary glands
© Cao-Lormeau; licensee BioMed Central Ltd. 2009
Received: 08 October 2008
Accepted: 25 March 2009
Published: 25 March 2009
Dengue virus (DENV), the etiological agent of dengue fever, is transmitted to the human host during blood uptake by an infective mosquito. Infection of vector salivary glands and further injection of infectious saliva into the human host are key events of the DENV transmission cycle. However, the molecular mechanisms of DENV entry into the mosquito salivary glands have not been clearly identified. Otherwise, although it was demonstrated for other vector-transmitted pathogens that insect salivary components may interact with host immune agents and impact the establishment of infection, the role of mosquito saliva on DENV infection in human has been only poorly documented. To identify salivary gland molecules which might interact with DENV at these key steps of transmission cycle, we investigated the presence of proteins able to bind DENV in salivary gland extracts (SGE) from two mosquito species. Using virus overlay protein binding assay, we detected several proteins able to bind DENV in SGE from Aedes aegypti (L.) and Aedes polynesiensis (Marks). The present findings pave the way for the identification of proteins mediating DENV attachment or entry into mosquito salivary glands, and of saliva-secreted proteins those might be bound to the virus at the earliest step of human infection. The present findings might contribute to the identification of new targets for anti-dengue strategies.
As the third millennium begins, classic dengue fever and the more severe dengue hemorrhagic fever and dengue shock syndrome, are still world public health concerns. Every year, dengue virus (DENV) infects more than 50 million people, with approximately 22 000 fatal cases . There are four antigenically distinct, but related, serotypes of DENV, a Flavivirus member of the family Flaviviridae. There is currently no vaccine available against DENV and vector control strategies fail to prevent the emergence of dengue epidemics, therefore new anti-dengue strategies need to be explored. A better understanding of the mechanisms and the molecules involved in the key steps of the DENV transmission cycle may lead to the identification of new anti-dengue targets.
DENV is transmitted by Aedes (Stegomyia) mosquitoes, principally Ae aegypti but also Ae albopictus and some endemic vectors like Ae polynesiensis in French Polynesia [2–4]. Infection of the female mosquito occurs during a blood feeding on a viremic human host. During the ten days following the ingestion of the infectious blood meal, viral replication occurs in different mosquito tissues and the virus finally infects the salivary glands [5–7]. Infection of mosquito salivary glands and subsequent injection of infectious saliva into the human host are key events of DENV transmission cycle.
In the present study, we investigated the presence of proteins able to bind to DENV in salivary gland extracts (SGE) from the Ae aegypti Bora-Bora strain (provided by the IRD, Montpellier, France) and an Ae polynesiensis wild colony from Atimaono-Tahiti (reared in our laboratory since 2000).
The salivary glands from 3–15 day-old adult females were dissected in phosphate buffer saline (PBS) 20 mM and immediately transferred into a vial containing a lysis buffer (1.5 mM MgCl2, 10 mM Tris-HCl, 10 mM NaCl, and 1% Nonidet P-40) and protease inhibitors (2 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride and 10 μg/ml of aprotinine). Each vial contained about 1,500 pairs of salivary glands and was stored at -80°C until needed . Salivary glands were then thawed and disrupted by sonication in an ice-water bath before being centrifugated at 9,000 × g for 15 minutes at 4°C. The supernatant containing SGE was recovered for protein quantification and stored at -80°C . To prepare semi-purified virus, the four reference strains of DENV (type 1, [Hawaii, Hawaii 1944]; type 2, [New Guinea C, Hawaii 1944]; type 3, [H-87, Philippines 1956]; type 4, [H-241, Philippines 1956]) and a clinical isolate obtained during the 1979 DEN4 epidemic in French Polynesia (amplified two times on Ae albopictus C6/36 cell cultures and stored at -80°C), were inoculated into the brain of suckling mice . Mouse brain viral antigen extracts were then clarified by centrifugation at 12,000 × g for 5 minutes and supernatants were applied into a discontinuous gradient of 65% and 15% (w/w) sucrose in GNTE buffer (200 mM Glycine, 100 mM NaCl, 50 mM Tris-HCl, 1 mM Ethylene diamine tetracetate [EDTA]). Sucrose gradients were centrifuged at 21,500 × g for 3.5 hours at 4°C. The visible band containing the viruses was removed, diluted with GNTE and pelleted by centrifugation at 16,500 × g for 2 hours at 4°C. Finally the viral pellet was resuspended in GNTE and stored at -80°C [11, 12]. For Virus Overlay Protein Binding Assay (VOPBA) total proteins from SGE were separated by SDS-10% polyacrylamide gel electrophoresis (PAGE), in non reducing conditions, before being transferred onto a nitrocellulose membrane . Membrane sheets (one lane per sheet) were then incubated in PBS-5% (w/v) skim milk overnight at 4°C. The membranes were then blocked in PBS-0.5% (w/v) Tween20-5% skim milk for 1 hour at 37°C, followed by a first wash with PBS-0.5% Tween20 for 5 minutes followed by an additional wash with a high-salt wash-buffer (PBS, 0.5% Tween20, 1% skim milk, 220 mM NaCl). Membranes were then incubated for 3 hours at 37°C with DENV antigen extracts diluted in high-salt wash-buffer to obtain a final titre of 7.3 Log10 TCID50/ml. Virus binding was then detected indirectly by incubating nitrocellulose membranes with either anti-DENV type-specific hyperimmune mouse ascitic fluid (HMAF) or anti-envelop (E) protein type-specific monoclonal antibodies (Mabs). After incubation with horseradish peroxidase conjugated sheep anti-mouse IgG, DENV binding was visualized on X-ray film using an enhanced chemiluminescent (ECL) substrate.
This is the first report on the presence of proteins able to bind to the four DENV serotypes in mosquito salivary gland extracts. Because SGE might contain both salivary gland tissue (basal lamina or salivary gland epithelial cells) and saliva-secreted proteins, the present work initiates the identification of either proteins mediating DENV infection of mosquito salivary glands or proteins bound to the virus at the early step of human infection.
DENV dissemination into mosquito tissues is dependant on the ability of the virus to penetrate several barriers: the midgut infection barrier (MIB), the midgut escape barrier (MEB) and the salivary glands. However, little is known about the mechanism and the molecules that allow the virus to pass these barriers. Most of the studies designed to identify putative DENV-receptors in mosquito tissues have been performed using the Ae albopictus C6/36 cell line model [14–16]. There are only few reports on the isolation of such receptors in whole mosquito tissues. Yazi Mendoza et al. (2002) first described the presence of a DEN4-binding protein in mosquito tissues (head, thorax and abdomen), more recently Mercado-Curiel et al. (2006) report the isolation of two DENV putative receptors in midgut extracts from Ae aegypti [12, 17]. However, receptors for all DENV serotypes in mosquito salivary glands have never been formally identified. Therefore, the next step to the present work would be to characterise the proteins that might be involved in DENV infection of Ae aegypti and Ae polynesiensis salivary glands. Once identified, such receptors would constitute key targets for transmission blocking strategies still explored for other vector-transmitted pathogens. As an example, the use of antibodies directed to Plasmodium sporozoïtes-receptors prevented the invasion of mosquito salivary glands by the parasite [18, 19].
The saliva of several mosquito species has been well studied for its anti-haemostatic properties allowing efficient blood feeding . The presence of pharmacologically active molecules such as platelet aggregation inhibitors, vasodilator agents and anti-coagulants have been described for Ae aegypti saliva [8, 21–24]. The effect of the saliva from pathogen-transmitting arthropods on mammal host immune response and the establishment of the pathogen has also been investigated. There are several reports on the tick or the sand fly saliva to enhance bacterial, viral or parasite infections . However, there has been little study on the arbovirus/mosquito saliva pair [26, 27]. Using an in vivo mouse model it was recently demonstrated that mosquito feeding or mosquito saliva potentiates West Nile virus infection . When focusing on the DENV/Ae aegypti pair, the only report is an in vitro study on human dendritic cells showing an inhibitory effect of vector saliva on DENV infection . Because of the absence of a reliable animal model, the impact of Ae aegypti saliva on DENV infection in the human host remains unknown. The identification of mosquito salivary proteins able to form complexes with DENV would lead to new hypotheses on the role of vector saliva on the establishment of viral infection. Such complexes would be a live illustration of the conceptual surface-mosaic model that address the potential significance of protein adsorption to the surface of micro-organisms at the early phase of host-pathogen relationships .
We are grateful to Pr Christian Herbaut (Université de la Polynésie Française), Yves Séchan, Albert Tetuanui and Jerôme Viallon (Institut Louis Malardé) for their contribution to the present work. We are also grateful to Dr Nick Karabatsos (CDC, Atlanta, USA) for providing anti-E monoclonal antibodies.
- World Health Organization: Impact of Dengue.[http://www.who.int/csr/disease/dengue/impact/en/index.html]
- Bancroft TL: On the aetiology of dengue fever. Australian Medical Gazette 1906, 25: 17-18.Google Scholar
- Cleland JB, Bradley B, McDonald W: Dengue fever in Australia. Its history and clinical course, its experimental transmission by Stegomyia fasciata , and the results of inoculation and other experiments. J Hyg 1918, 16: 317-418.PubMed CentralView ArticlePubMedGoogle Scholar
- Rosen L, Rozeboom LE, Sweet BH, Sabin AB: The transmission of dengue by Aedes polynesiensis Marks. Am J Trop Med Hyg 1954, 3: 878-882.PubMedGoogle Scholar
- Kuberski T: Fluorescent antibody studies on the development of dengue-2 virus in Aedes albopictus (Diptera: Culicidae). J Med Entomol 1979, 16: 343-349.View ArticlePubMedGoogle Scholar
- Linthicum KJ, Platt K, Myint KS, Lerdthusnee K, Innis BL, Vaughn DW: Dengue 3 virus distribution in the mosquito Aedes aegypti : an immunocytochemical study. Med Vet Entomol 1996, 10: 87-92. 10.1111/j.1365-2915.1996.tb00086.xView ArticlePubMedGoogle Scholar
- Salazar MI, Richardson JH, Sanchez-Vargas I, Olson KE, Beaty BJ: Dengue virus type 2: replication and tropisms in orally infected Aedes aegypti mosquitoes. BMC Microbiol 2007.,7(9):Google Scholar
- Stark KR, James AA: Isolation and characterization of the gene encoding a novel factor Xa-directed anticoagulant from the yellow fever mosquito, Aedes aegypti . J Biol Chem 1998,273(33):20802-20809. 10.1074/jbc.273.33.20802View ArticlePubMedGoogle Scholar
- Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3View ArticlePubMedGoogle Scholar
- Parc F, Tetaria C, Pichon G: Dengue outbreak by virus type 4 in French Polynesia. Part II – Preliminary biological observations on epidemiology and physiopathology of the disease [in french]. Médecine Tropicale 1981,41(1):97-102.PubMedGoogle Scholar
- Cardosa MJ, Hooi TP, Shaari NS: Development of a dot enzyme immunoassay for dengue 3: a sensitive method for the detection of antidengue antibodies. J Virol Methods 1988, 22: 81-88. 10.1016/0166-0934(88)90090-0View ArticlePubMedGoogle Scholar
- Yazi Mendoza M, Salas-Benito JS, Lanz-Mendoza H, Hernández-Martínez S, Del Angel RM: A putative receptor for dengue virus in mosquito tissues: localization of a 45-Kda glycoprotein. Am J Trop Med Hyg 2002,67(1):76-84.PubMedGoogle Scholar
- Ludwig GV, Kondig JP, Smith JF: A putative receptor for venezuelan equine encephalitis virus from mosquito cells. J Virol 1996, 70: 5592-5599.PubMed CentralPubMedGoogle Scholar
- Salas-Benito JS, Del Angel RM: Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus. J Virol 1997,71(10):7246-7252.PubMed CentralPubMedGoogle Scholar
- Munoz ML, Cisneros A, Cruz J, Das P, Tovar R, Ortega A: Putative dengue virus receptors from mosquito cells. FEMS Microbiol Lett 1998, 168: 251-258.View ArticlePubMedGoogle Scholar
- Reyes-del Valle J, Del Angel RM: Isolation of putative dengue virus receptor molecules by affinity chromatography using a recombinant E protein ligand. J Virol Methods 2004,116(1):95-102. 10.1016/j.jviromet.2003.10.014View ArticlePubMedGoogle Scholar
- Mercado-Curiel RF, Esquinca-Avilés HA, Tovar R, Diaz-Badillo A, Camacho-Nuez M, Munoz ML: The four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cells. BMC Microbiol 2006.,6(85):Google Scholar
- Brennan JDG, Kent M, Dhar R, Fujioka H, Kumer N: Anopheles gambiae salivary gland proteins as putative targets for blocking transmission of malaria parasites. Proc Natl Acad Sci USA 2000, 97: 13859-13864. 10.1073/pnas.250472597PubMed CentralView ArticlePubMedGoogle Scholar
- Korochkina S, Barreau C, Pradel G, Jeffery E, Li J, Natarajan R, Shabanowitz J, Hunt D, Frevert U, Vernick KD: A mosquito-specific protein family includes candidate receptors for malaria sporozoites invasion of salivary glands. Cell Microbiol 2006,8(1):163-175. 10.1111/j.1462-5822.2005.00611.xView ArticlePubMedGoogle Scholar
- Champagne DE: Antihemostatic Molecules from saliva of blood-feeding arthropods. Pathophysiol Haemost Thromb 2005, 34: 221-227. 10.1159/000092428View ArticlePubMedGoogle Scholar
- Ribeiro JM, Sarkis JJF, Rossignol PA, Spielman A: Salivary apirase of Aedes aegypti : Characterization and secretory fate. Comp Biochem Physiol B 1984, 79: 81-86. 10.1016/0305-0491(84)90081-6View ArticlePubMedGoogle Scholar
- Ribeiro JM: Characterization of a vasodilator from the salivary glands of the yellow fever mosquito Aedes aegypti . J Exp Biol 1992, 165: 61-71.PubMedGoogle Scholar
- Champagne DE, Ribeiro JM: Sialokinins I and II: vasodilatory tachykinins from the yellow fever mosquito Aedes aegypti . Proc Natl Acad Sci USA 1994, 91: 138-142. 10.1073/pnas.91.1.138PubMed CentralView ArticlePubMedGoogle Scholar
- Champagne DE, Smartt CT, Ribeiro JM, James AA: The salivary gland-specific apyrase of the mosquito Aedes aegypti is a member of the 5'-nucleotidase family. Proc Natl Acad Sci USA 1995, 92: 694-698. 10.1073/pnas.92.3.694PubMed CentralView ArticlePubMedGoogle Scholar
- Titus RG, Bishop JV, Mejia JS: The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission. Parasite Immunol 2006, 28: 131-141.PubMedGoogle Scholar
- Osorio JE, Godsey MS, Defoliart GR, Yuill TM: La Crosse viremias in white-tailed deer and chipmunks exposed by injection or mosquito bite. Am J Trop Med Hyg 1996,54(4):338-342.PubMedGoogle Scholar
- Limesand KH, Higgs S, Pearson LD, Beaty BJ: Potentation of vesicular stomatitis New Jersey virus infection in mice by mosquito saliva. Parasite Immunology 2000,22(9):461-46. 10.1046/j.1365-3024.2000.00326.xView ArticlePubMedGoogle Scholar
- Schneider BS, Soong L, Girard YA, Campbell G, Mason P, Higgs S: Potentiation of West Nile Encephalitis by mosquito feeding. Viral Immunol 2006,19(1):74-82. 10.1089/vim.2006.19.74View ArticlePubMedGoogle Scholar
- Ader DB, Celluzzi C, Bisbing J, Gilmore L, Gunther V, Peachman KK, Rao M, Barvir D, Sun W, Palmer DR: Modulation of dengue virus infection of dendritic cells by Aedes aegypti saliva. Viral Immunol 2004,17(2):252-265. 10.1089/0882824041310496View ArticlePubMedGoogle Scholar
- Mejia JS, Moreno F, Muskus C, Vélez ID, Titus RG: The surface-mosaic model in host-parasite relationships. Trends Parasitol 2006,20(11):508-510. 10.1016/j.pt.2004.08.005View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.